BCYC - Company ID 0001761612
The table below shows BICYCLE THERAPEUTICS plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $34.06M | $629.00K | $887.00K | $11.73M | $2.92M | $9.98M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $33.42M | $41.16M | $48.90M | $58.43M | $71.03M | $59.06M |
BICYCLE THERAPEUTICS plc reported annual revenue of $72.59M for fiscal year 2025. That is up 105.8% from $35.27M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $2.06M (FY 2017) to $72.59M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $14.11M |
| $14.03M |
| $17.47M |
| $18.86M |
| $18.49M |
| $21.12M |
| Operating income | -$13.48M | -$54.56M | -$65.48M | -$65.55M | -$86.60M | -$70.20M |
| Income tax | $1.17M | $90.00K | $172.00K | $205.00K | -$231.00K | -$1.09M |
| Net income | -$10.48M | -$50.33M | -$60.83M | -$59.10M | -$78.95M | -$60.75M |
| EPS (diluted) | -$0.15 | -$0.72 | -$0.87 | -$0.85 | -$1.14 | -$0.88 |